Hey, I wrote an article for @HOPArx News! Page 21 hoparx.org/about-us/hopa-… join the conversation at https://www.linkedin.com/posts/meganhartranft_hopa-news-activity-7422467260990169088-XUnK?utm_source=share&utm_medium=member_ios&rcm=ACoAAAYM_JgBsvuybEk8knSlts25O-psJBmthO4

When I was a #pharmacy student, it felt like rotations flew by. As a preceptor, I swear they go even faster! I blinked and Block 5 was over. How?? I still have so much more wisdom to impart! Thank you @UHSPedu for the awesome learners! #PharmEd

In Montana for @pgrnhub Scientific Meeting. Can’t wait for 3 days packed with solving challenges to clinical PGx implementation. Also, more beautiful morning hikes.

No other professional meeting brings me as much joy as HOPA Annual Conference. So great to catch up with #OncoPharm friends in Portland last week.

St Louis: please remember to vote today! And it’s not just mayor and comptroller - there are also elections for school board, community college trustees, and in a couple wards, alderperson too. www.stlouis-mo.gov/elections/in...

So tempted to stand at my airplane gate bound for PDX and shout “Where’s my #OncoPharm crowd?!?” (I won’t, I don’t like to cause a scene. But I will be scrutinizing the lines carefully for familiar faces, or just people who look like fellow pharmacy nerds.) #HOPA2025

Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview Podcast Episode · OncoPharm · 04/08/2025 · 12m

Another great OncoPharm podcast episode out today. If you’re heading to #HOPA2025, do yourself a favor and download to listen on your travels. @bossaer.bsky.social has excellent recs for fun outside the conference! podcasts.apple.com/us/podcast/o...

AI Tool May Help to Predict Which Patients With Prostate Cancer May Benefit From Focal Therapy A novel artificial intelligence (AI) tool may help to determine which men with prostate cancer are most likely to benefit from partial gland cryoablation.

It seems to me that some of the best applications of AI in cancer are in identifying which patients can avoid unnecessary treatment. In this case, prostate cancer patients eligible for focal therapy instead of more aggressive interventions. Via @ascopost.bsky.social ascopost.com/news/march-2...

An aerial over Post-Dispatch Lake and the Boathouse in Forest Park facing east shows the Saint Louis Arch centered in a sprawling cityscape illuminated by a bright orange sky.

I see the Arch! Happy 314 Day, St. Louis. Come play in Forest Park and visit our friends at the Art Museum, History Museum, Zoo, Science Center and more. SO many amenities make this an amazing and very St. Louis urban park.

Our cancer advocates are joining One Voice Against Cancer on Capitol Hill today to meet with lawmakers to discuss the critical need for increased funding for the NCI, NIH & CDC Cancer in the FY25 spending bill!

We can’t afford to pause progress on #CancerResearch & #CancerPrevention. #CancerVoice25

Really pleased with the sourdough bagels I made this weekend

Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease an...

Kudos @americanheart.bsky.social and Dr. Tochi Okwuosa on the new AI in cardio-oncology statement. Great read, I loved the emphasis on using tech to make cardioprotective monitoring & interventions more standardized and accessible for #cancer patients. www.ahajournals.org/doi/10.1161/...

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio Myriad Genetics entered into a strategic collaboration with PATHOMIQ to exclusively license its AI technology platform for prostate cancer in the US....

Another molecular diagnostics partnerships announcement:
Myriad Genetics & PATHOMIQ . Cool to see these collaborations leveraging AI and precision medicine to improve clinical decision making. #cancer #CDSS www.globenewswire.com/news-release...

Stemline Therapeutics to Deploy Tempus Next’s AI-Enabled Care Pathway Intelligence Platform Tempus and Stemline announced a new collaboration to improve the use of ESR1 testing in metastatic breast cancer (mBC).

I'm excited about the partnership news re: Stemline & Tempus. It will enable notification of clinicians directly in their workflow when ESR1 testing is missing at disease progression. Hope this leads to more timely clinical decisions! #CDSS #mbcsm hitconsultant.net/2025/02/21/s...

Douglas Flora: A Cure for Cancer - Closer Than We Think? - OncoDaily Douglas Flora: A Cure for Cancer - Closer Than We Think? / artificial intelligence, cancer, cure for cancer, Douglas Flora, fight against cancer, Global

A Cure for Cancer – Closer Than We Think? - Douglas Flora

oncodaily.com/blog/douglas...

#Cancer #CancerCare #Medicine #Health #CancerTreatment #Oncology #OncoDaily

‘It’s a game changer’: Local scientist’s cancer research working to find easier way to save lives A local scientist is using artificial intelligence to find new uses for existing drugs to hopefully save both lives and money.

Great feature on the startup Reboot Rx. Love the work the team is doing to repurpose generic drugs for #cancer patients. We need more efforts like this focused on bringing down costs of care and expanding indications for safe medications. #oncopharm www.boston25news.com/news/local/i...

CancerX Launches 2025 Accelerator to Drive Innovation in Oncology CancerX, a public-private partnership designed to accelerate innovation in the fight against cancer, announced today the launch of its 2025 Accelerato

Congrats to all the startups selected for the 2025 CancerX Accelerator cohort. Exciting to see so many innovative ideas that will impact patient and caregivers on the cancer care journey. www.businesswire.com/news/home/20... #cancerx

Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module - PubMed In the past decade, pharmacogenomic (PGx) testing to predict drug response have emerged into clinical care. Clinical decision support (CDS) has and continues to play a key role in educating prescriber...

Cool paper out of @UFPharmacy on integrating the Epic PGx module. It's going on the required reading list next time I take pharmacy students. pubmed.ncbi.nlm.nih.gov/39960348/

The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. Read our statement: https://buff.ly/4gRXNB8

Hello Bluesky. I've been wanting to get more "social" again, and hoping to start fresh with a more scientifically-minded platform. I'll probably be dual-posting here and that other site, but we'll see how it goes for a while. Looking forward to talking about #cancer, #pharmacy, and maybe #sourdough.